Hypovitaminosis D according to psychiatric diagnosis groups: A study with control group

Amaç: Vitamin D eksikliğinin çeşitli psikiyatrik bozukluklar için risk faktörü olabileceği ifade edilmektedir. Bu çalışmada dört farklı psikiyatrik bozukluk (şizofreni, bipolar bozukluk, depresyon, anksiyete bozukluğu) ve sağlıklı kontroller arasında 25(OH)D düzeyini karşılaştırmak ve yatarak tedavi gören psikiyatri hastalarda vitamin D eksiklik nedenleri araştırmak amaçlanmıştır. Yöntem: Bu retrospektif çalışmaya bir psikiyatri kliniğinde 2012-2014 yılları arasında yatarak tedavi olan 974 birey [depresyon (n=553), bipolar bozukluk (n=135), şizofreni (n=186) ve anksiyete bozukluğu (n=100)] ve kontrol grubuna psikiyatrik tanısı olmayan 574 birey dahil edildi. 25(OH)D düzeyinin 21 ng/mL düşük olması vitamin D eksikliği olarak kabul edildi. Bulgular: Kontrol grubu 25(OH)D düzey ortalaması diğer dört psikiyatrik tanı gruplarının 25(OH)D düzey ortalamasına göre anlamlı olarak yüksek bulundu (p0.05). Her bir çalışma grubunda yaş grupları arasında 25(OH)D düzeyleri karşılaştırıldığında 35-54 yaş arası şizofreni hastalarının vitamin D düzeyleri 18-34 yaşrası şizofreni hastalarına göre anlamlı düşük bulundu (p

Psikiyatrik tanı gruplarına göre vitamin Deksikliği: Kontrol gruplu bir çalışma

Objective: One of the risk factor for different psychiatric disorders has been indicated as hypovitaminosis D. The present study aimed to compare 25 (OH) D level between 4 different types of psychiatric disorders (schizophrenia, bipolar disorder, depression and anxiety disorder) and healthy controls, and to assess the risk factors of hypovitaminosis D in psychiatric inpatients. Method: This retrospective study included 974 individuals [depression (n=553), bipolar disorder (n=135), schizophrenia (n=186) and anxiety disorder (n=100)] who received inpatient treatment in psychiatry clinic between 2012 and 2014, and 574 individuals in control group who were not diagnosed with a psychiatric condition. A 25 (OH) D level less than 21 ng/mL was considered to indicate hypovitaminosis D. Results: 25 (OH) D level average of the control group was found to be significantly higher than that of the four psychiatric diagnosis groups (p

PDF

___

Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distri- bution of the vitamin D receptor and 1 alpha-hydroxylase in hu- man brain. J Chem Neuroanat 2005; 29: 21-30.
Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain func- tion and the links between low levels of vitamin D and neuro- psychiatric disease. Front Neu- roendocrinol 2013; 34: 47-64.
Nesby-O'Dell S1, Scanlon KS, Cogswell ME, Gillespie C, Hol- lis BW, Looker AC, Allen C, Doughertly C, Gunter EW, Bowman BA. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2002; 76: 187-92.
Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D in- sufficiency among free-living healthy young adults. Am J Med. 2002 Jun 1;112(8):659-62.
Leedahl DD, Cunningham JL, Drake MT, Mundis CB, Kung S, Frye MA, Lapid MI. Hypovitaminosis D in psychiatric inpatients: clinical correlation with depressive symptoms, cognitive impairment, and prescribing practices. Psychosomatics 2013; 54: 257-62
McGrath JJ, Burne TH, Féron F, Mackay-Sim A, Eyles DW. De- velopmental vitamin D deficien- cy and risk of schizophrenia: a 10-year update. Schizophr Bull 7. Berk M, Jacka FN, Williams LJ, Ng F, Dodd S, Pasco JA. Is this D vitamin to worry about? Vit- amin D insufficiency in an inpa- tient sample. Aust N Z J Psychi- atry. 2008; 42: 874-8.
Holick MF. Vitamin D deficien- cy. N Engl J Med 2007; 357: 266-81.
Holick MF, Binkley NC, Bis- choff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society. Evaluation, treatment, and prevention of vitamin D de- ficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.
Zeng Q, Dellenbaugh T, Maldo- nado M, Moon J, Hornstra R. Vitamin D status of psychiatric inpatients at a community teach- ing hospital in the Midwest. Nord J Psychiatry 2015; 18:1-7. [Epub ahead of print]
Rylander M, Verhulst S. Vita- min D insufficiency in psychiat- ric inpatients. J Psychiatr Pract 2013;19: 296-300.
Belzeaux R, Boyer L, Ibrahim el C, Féron F, Leboyer M, Fond G. Mood disorders are associated with a more severe hypovita- minosis D than schizophrenia. Psychiatry Res 2015; 30; 229: 613-6.
Schneider B, Weber B, Frensch A, Stein J, Fritz J. Vitamin D in schizophrenia, major depression and Transm 839-42. Neural (Vienna).
;107: 14. Parker G, Brotchie H. 'D' for de- pression: any role for vitamin D? 'Food for Thought' II. Acta Psychiatr Scand. 2011; 124: 243-9.
Humble MB, Gustafsson S, Be- jerot S. Low serum levels of 25- hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with sea- son, age, ethnic origin and psy- chiatric diagnosis. J Steroid Bi- ochem Mol Biol 2010; 121: 467-70.
McCue RE, Charles RA, Oren- dain GC, Joseph MD, Abanishe JO. Vitamin d deficiency among psychiatric inpatients. Prim Care Companion CNS Disord. 2012; 14 (2).
Itzhaky D, Amital D, Gorden K, Bogomolni A, Arnson Y, Amit- al H. Low serum vitamin D con- centrations in patients with schizophrenia. Isr Med Assoc J 2012; 14: 88-92.
Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM, Beekman AT, Smit JH, Penninx BW. The association between low vitamin D and depressive disorders. Mol Psychiatry 2014; 19: 444-51.
Mawer EB, Berry JL, SommerTsilenis E, Beykirch W, Kuhlwein A, Rohde BT. Ultraviolet irradiation increases serum 1,25-dihydroxyvitamin D in vitamin-D-replete adults. Miner Electrolyte Metab 1984; 10:117-21.
Stumpf WE, Privette TH. Light, vitamin D and psychiatry. Role of 1,25 dihydroxyvitamin D3 (soltriol) in etiology and therapy of seasonal affective disorder and other mental processes. Psychopharmacology 1989; 97: 285-94.
Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl). 1998 Feb;135(4):319-23.
Edström DW, Linder J, Wennersten G, Brismar K, Ros AM. Phototherapy with ultraviolet radiation: a study of hormone parameters and psychological effects. J Eur Acad Dermatol Venereol 2010; 24: 403-9.
Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013; 202: 100-7.
Penckofer S, Kouba J, Byrn M,Estwing Ferrans C. Vitamin D and depression: where is all the sunshine? Issues Ment Health Nurs. 2010; 31: 385-93
Kerr DC, Zava DT, Piper WT, Saturn SR, Frei B, Gombart AF. Associations between vitamin D levels and depressive symptoms in healthy young adult women. Psychiatry Res 2015; 227: 46-51.
Kjærgaard M, Waterloo K, Wang CE, Almås B, Figenschau Y, Hutchinson MS, Svartberg J, Jorde R. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry 2012; 201: 360-8.
Burne TH, Becker A, Brown J, Eyles DW, Mackay-Sim A, McGrath JJ. Transient prenatal Vitamin D deficiency is associated with hyperlocomotion in adult rats. Behav Brain Res 2004; 154: 549-55.
Belvederi Murri M, Respino M, Masotti M, Innamorati M, Mondelli V, Pariante C, Amore M. Vitamin D and psychosis: mini meta-analysis. Schizophr Res 2013; 150: 235-9
Bi?íková M, Du?ková M, Vítk? J, Kalvachová B, ?ípová D, Mohr P, Stárka L. Vitamin D in anxiety and affective disorders. Physiol Res 2015; 64 Suppl 2: S101-3.
Black LJ, Jacoby P, Allen KL, Trapp GS, Hart PH, Byrne SM, Mori TA, Beilin LJ, Oddy WH. Low vitamin D levels are associated with symptoms of depression in young adult males. Aust N Z J Psychiatry. 2014; 48: 464- 71
31. Tunstall-Pedoe H, Woodward M, Hughes M, Anderson A, Kennedy G, Belch J, Kuulasmaa K; MORGAM Investigators. Prime mover or fellow traveller: 25-hydroxy vitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC). Int J Epidemiol 2015;44: 1602-12.
Brot C, Jorgensen NR, Sorensen OH. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr 1999; 53: 920-6.
Scragg R, Camargo CA Jr. Frequency of leisure-time physical activity and serum 25- hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2008; 168: 577-86.
Nanri A, Mizoue T, Matsushita Y, Poudel-Tandukar K, Sato M, Ohta M, Mishima N. Association between serum 25- hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season. Eur J Clin Nutr 2009; 63: 1444-7.
Dana-Alamdari L, Kheirouri S, Noorazar SG. Serum 25- Hydroxyvitamin D in Patients with Major Depressive Disorder. Iran J Public Health 2015; 44: 690-7.